MNMutinta Nalubamba‐Phiri

Mutinta Nalubamba‐Phiri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mutinta Nalubamba‐Phiri has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Classifying perinatal mortality using verbal autopsy: is there a role for nonphysicians?

    by Cyril Engmann, John Ditekemena, Imtiaz Jehan, Ana Garces, Mutinta Phiri, Vanessa Thorsten, Manolo Mazariegos, Elwyn Chomba, Omrana Pasha, Antoinette Tshefu, et al.

    Because of a physician shortage in many low-income countries, the use of nonphysicians to classify perinatal mortality (stillbirth and early neonatal death) using verbal autopsy could be useful.


  • Open Access

    Causes of morbidity among HIV‐infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia

    by Mwangelwa Mubiana‐Mbewe, Carolyn Bolton‐Moore, Yolan Banda, Namwinga Chintu, Mutinta Nalubamba‐Phiri, Mark Giganti, M. Brad Guffey, Pauline Sambo, Elizabeth M. Stringer, Jeffrey S. A. Stringer, et al.

    Summary: Objectives  To describe the pattern of incident illness in children after initiation of antiretroviral therapy (ART) in a large public health sector programme in Lusaka, Zambia.Methods  Systematic chart review to retrospectively extract data from medical records of children (i.e. Results  Between May 2004 and June 2006, 1705 HIV‐infected children initiated ART. Of these, 1235 (72%) had their medical records reviewed. Median age at ART initiation was 77 months and 554 (45%) were females. Eight hundred and forty‐one (68%) children had an incident condition during this period, with a median time of occurrence of 64 days from ART initiation. Twenty‐eight incident conditions were documented. When categorized, the most common were mucocutaneous conditions [incidence rate (IR): 70.6 per 100 child‐years, 95% CI: 64.5–77.2] and upper respiratory tract infection (IR: 70.1 per 100 child‐years; 95% CI: 64.0–76.7). Children with severe immunosuppression (i.e. CD4 < 10%) were more likely to develop lower respiratory tract infection (16.3%vs. 10.2%; P = 0.003) and mucocutaneous conditions (43.9% vs. 35.3%; P = 0.005) than those with CD4 ≥ 10%.Conclusion  There is a high incidence of new illness after ART initiation, emphasizing the importance of close monitoring during this period. Early initiation of ART and use of antimicrobial prophylaxis may also help to reduce the occurrence of such co‐morbidities.